Literature DB >> 32258530

Liver transplantation for alcoholic hepatitis.

Lindsey C Shipley1, Ashwani K Singal2.   

Abstract

Alcoholic hepatitis (AH) is associated with a high short-term mortality. Currently, most transplant centers require minimum six months of abstinence from alcohol use before considering liver transplant for patients with end stage liver disease. Some recent data are emerging on the benefits and safety of early liver transplantation for patients with severe AH, a population who cannot meet the minimum six months sobriety. This article reviews the current status, benefits, challenges, barriers, and future prospects on early liver transplantation in patients with severe, acute AH. 2020 Translational Gastroenterology and Hepatology. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; alcohol use post-transplant; allograft survival; liver transplantation

Year:  2020        PMID: 32258530      PMCID: PMC7063489          DOI: 10.21037/tgh.2019.11.17

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  4 in total

1.  Liver transplantation in patients with non-alcoholic steatohepatitis and alcohol-related liver disease: the dust is yet to settle.

Authors:  Sanjaya K Satapathy; David E Bernstein; Nitzan C Roth
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 2.  Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management.

Authors:  Arshi Khanam; Shyam Kottilil
Journal:  Front Med (Lausanne)       Date:  2021-11-08

3.  Do Patients with Autoimmune Conditions Have Less Access to Liver Transplantation despite Superior Outcomes?

Authors:  Stephanie S Keeling; Malcolm F McDonald; Adrish Anand; Cameron R Goff; Caroline R Christmann; Spencer C Barrett; Michael Kueht; John A Goss; George Cholankeril; Abbas Rana
Journal:  J Pers Med       Date:  2022-07-17

4.  When demand exceeds supply: Liver transplantation due to alcohol use disorder in Austria.

Authors:  Stephan Listabarth; Andrea Gmeiner; Nathalie Pruckner; Sandra Vyssoki; Andreas Wippel; Daniel König
Journal:  Neuropsychiatr       Date:  2020-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.